Douglas Kerr insider trades

Open-market stock purchases and sales by Douglas Kerr, Chief Medical Officer at Dyne Therapeutics, Inc, from SEC Form 4 filings since Jan 11, 2021.

Recent trades

DateStockTradeValue
Sep 8, 2026DYN Dyne Therapeutics, IncSold$24.4K
Sep 4, 2026DYN Dyne Therapeutics, IncSold$91.2K
Aug 13, 2026DYN Dyne Therapeutics, IncSold$40.9K
Jun 16, 2026DYN Dyne Therapeutics, IncSold$16.3K
May 13, 2026DYN Dyne Therapeutics, IncSold$28.7K
Mar 5, 2026DYN Dyne Therapeutics, IncSold$13.5K
Feb 12, 2026DYN Dyne Therapeutics, IncBought (not open market)—
Feb 12, 2026DYN Dyne Therapeutics, IncBought (not open market)—
Dec 5, 2025DYN Dyne Therapeutics, IncSold$18.2K

Companies traded

  • DYN Dyne Therapeutics, Inc: 11 sales, last Sep 8, 2026
  • GBIO Generation Bio Co: 16 sales, last Jan 29, 2024

Get free alerts when Douglas Kerr files a new trade →